# Mary Beth Beasley

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mary-beth-beasley/

## Facts

| Field | Value |
| --- | --- |
| Citations | 30,168 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 64 |
| i10-index | 127 |
| Last Known Institution | Icahn School of Medicine at Mount Sinai |
| OpenAlex ID | https://openalex.org/A5020295260 |
| ORCID iD | https://orcid.org/0000-0003-2340-1897 |
| Works | 293 |

## Researcher papers

- [PD-L1 as a biomarker of response to immune-checkpoint inhibitors](https://scholariq.org/papers/pd-l1-as-a-biomarker-of-response-to-immune-checkpoint-inhibitors/)
- [The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015](https://scholariq.org/papers/the-2021-who-classification-of-lung-tumors-impact-of-advances-since-2015/)
- [Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology](https://scholariq.org/papers/updated-molecular-testing-guideline-for-the-selection-of-lung-cancer-patients/)
- [The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer](https://scholariq.org/papers/the-iaslc-lung-cancer-staging-project-proposals-for-coding-t-categories-for/)
- [A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee](https://scholariq.org/papers/a-grading-system-for-invasive-pulmonary-adenocarcinoma-a-proposal-from-the/)
- [Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification](https://scholariq.org/papers/single-cell-analysis-of-human-non-small-cell-lung-cancer-lesions-refines-tumor/)
- [Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer](https://scholariq.org/papers/best-practices-recommendations-for-diagnostic-immunohistochemistry-in-lung/)
- [PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee](https://scholariq.org/papers/pd-l1-testing-for-lung-cancer-in-2019-perspective-from-the-iaslc-pathology/)
- [The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee](https://scholariq.org/papers/the-promises-and-challenges-of-tumor-mutation-burden-as-an-immunotherapy/)
- [Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee](https://scholariq.org/papers/predictive-biomarkers-for-immunotherapy-in-lung-cancer-perspective-from-the/)
- [Rapid On-Site Evaluation of Endobronchial Ultrasound–Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society](https://scholariq.org/papers/rapid-on-site-evaluation-of-endobronchial-ultrasound-guided-transbronchial/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)

## Researcher university

- [Icahn School of Medicine at Mount Sinai](https://scholariq.org/institutions/icahn-school-of-medicine-at-mount-sinai/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.